^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    CXCL13 overexpression

    i
    Other names: CXCL13, ANGIE, ANGIE2, BCA-1, BLC, BLR1L, SCYB13, Chemokine (C-X-C motif) ligand 13
    Entrez ID:
    10563
    Related biomarkers:
    Expression
    Mutation
    Others
    2ms
    Single cell deciphering of progression trajectories of the tumor ecosystem in head and neck cancer. (PubMed, Nat Commun)
    Finally, we delineate the distinct features of malignant epithelial cells in primary and recurrent tumors, providing a theoretical foundation for the precise selection of targeted therapy for tumors at different stages. In summary, the current study offers a comprehensive landscape and deep insight into epithelial and microenvironmental reprogramming throughout initiation, progression, lymph node metastasis and recurrence of head and neck squamous cell carcinoma.
    Journal
    |
    CD8 (cluster of differentiation 8) • SPP1 (Secreted Phosphoprotein 1) • CXCL13 (Chemokine (C-X-C motif) ligand 13) • POSTN (Periostin)
    |
    CXCL13 expression • CXCL13 overexpression
    2ms
    Serum CXCL13 level is related to treatment response and predicts disease prognosis in Waldenström macroglobulinemia. (PubMed, Ann Hematol)
    Our study concludes that serum CXCL13 levels decrease in WM patients treated with various regimens and correlate with treatment response. Detecting serum CXCL13 at baseline or after treatment help in predicting prognosis.
    Journal
    |
    B2M (Beta-2-microglobulin) • CXCL13 (Chemokine (C-X-C motif) ligand 13)
    |
    CXCL13 overexpression